Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Change in Inventory (2018 - 2025)

TransMedics (TMDX) has 8 years of Change in Inventory data on record, last reported at $6.5 million in Q4 2025.

  • For Q4 2025, Change in Inventory rose 257.87% year-over-year to $6.5 million; the TTM value through Dec 2025 reached $7.7 million, down 7.63%, while the annual FY2025 figure was $7.7 million, 7.63% down from the prior year.
  • Change in Inventory reached $6.5 million in Q4 2025 per TMDX's latest filing, down from $6.9 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $10.1 million in Q3 2023 and bottomed at -$4.1 million in Q4 2024.
  • Average Change in Inventory over 5 years is $2.9 million, with a median of $2.2 million recorded in 2021.
  • Peak YoY movement for Change in Inventory: surged 667.98% in 2022, then plummeted 260.16% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $930000.0 in 2021, then surged by 107.53% to $1.9 million in 2022, then skyrocketed by 265.96% to $7.1 million in 2023, then crashed by 158.57% to -$4.1 million in 2024, then skyrocketed by 257.87% to $6.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were $6.5 million in Q4 2025, $6.9 million in Q3 2025, and -$3.7 million in Q2 2025.